Korea Drug Development Fund (KDDF) — New Drug R&D
Supports organizations through Korea Drug Development Fund New Drug Innovation, helping them build novel medicine programs.
About
The Korea Drug Development Fund (KDDF) supports Korean new-drug R&D from lead-candidate discovery through non-clinical and Phase 1/2 clinical development. Season 1 (2011–2020) funded 159 completed projects across oncology, CNS, cardiovascular, infectious, immunology, and metabolic indications, with academic and corporate awardees including Seoul National University, KAIST, Hanmi Pharmaceutical, SK…
Biotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.